As of 2025-07-03, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (40.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.52 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -1264.3%.
The range of the Relative Valuation is (33.10) - (45.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 23.6x | 19.6x |
| Forward P/E multiples | 17.0x - 28.2x | 22.6x |
| Fair Price | (33.10) - (45.89) | (40.98) |
| Upside | -1040.3% - -1403.8% | -1264.3% |
| Date | P/E |
| 2025-06-27 | -1.70 |
| 2025-06-26 | -1.71 |
| 2025-06-25 | -1.68 |
| 2025-06-24 | -1.70 |
| 2025-06-23 | -1.66 |
| 2025-06-20 | -1.64 |
| 2025-06-18 | -1.73 |
| 2025-06-17 | -1.57 |
| 2025-06-16 | -1.68 |
| 2025-06-13 | -1.66 |
| 2025-06-12 | -1.77 |
| 2025-06-11 | -1.72 |
| 2025-06-10 | -1.79 |
| 2025-06-09 | -1.73 |
| 2025-06-06 | -1.73 |
| 2025-06-05 | -1.67 |
| 2025-06-04 | -1.66 |
| 2025-06-03 | -1.69 |
| 2025-06-02 | -1.64 |
| 2025-05-30 | -1.54 |
| 2025-05-29 | -1.58 |
| 2025-05-28 | -1.52 |
| 2025-05-27 | -1.47 |
| 2025-05-23 | -1.50 |
| 2025-05-22 | -1.46 |
| 2025-05-21 | -1.47 |
| 2025-05-20 | -1.57 |
| 2025-05-19 | -1.51 |
| 2025-05-16 | -1.45 |
| 2025-05-15 | -1.43 |
| 2025-05-14 | -1.42 |
| 2025-05-13 | -1.46 |
| 2025-05-12 | -1.60 |
| 2025-05-09 | -1.54 |
| 2025-05-08 | -1.54 |
| 2025-05-07 | -1.52 |
| 2025-05-06 | -1.62 |
| 2025-05-05 | -1.71 |
| 2025-05-02 | -1.67 |
| 2025-05-01 | -1.69 |
| 2025-04-30 | -1.71 |
| 2025-04-29 | -1.59 |
| 2025-04-28 | -1.68 |
| 2025-04-25 | -1.65 |
| 2025-04-24 | -1.64 |
| 2025-04-23 | -1.60 |
| 2025-04-22 | -1.51 |
| 2025-04-21 | -1.41 |
| 2025-04-17 | -1.38 |
| 2025-04-16 | -1.34 |